Fujii, Yosuke
Hirota, Kiichi
Muranishi, Kentaro
Mori, Yumiko
Kambara, Kei
Nishikawa, Yoshitaka
Hashiguchi, Mitsuko
Funding for this research was provided by:
the branding program as a world-leading research university on intractable immune and allergic diseases
Article History
Received: 2 July 2022
Accepted: 14 November 2022
First Online: 26 November 2022
Declarations
:
: This research was approved by the ethical committee of Otsu City Hospital (approval number 23; approval date, June 18, 2020). This study was conducted under the Declaration of Helsinki and STROBE reporting guidelines. The need for informed consent was waived by the ethics committee of Otsu City Hospital due to the retrospective nature of the study.
: Consent for publication was waived by the ethical committee of Otsu City Hospital due to the retrospective study.
: The authors report that there are no conflicts of interest to declare.